4.6 Article Proceedings Paper

Farnesylated proteins and cell cycle progression

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 84, Issue -, Pages 64-70

Publisher

WILEY
DOI: 10.1002/jcb.10067

Keywords

farnesyltransferase inhibitor; cell cycle; Rheb; Ras; Rho; CNEP-E,F

Funding

  1. NCI NIH HHS [CA 41996] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Post-translational modification of proteins by the addition of a farnesyl group is critical for the function of a number of proteins involved in signal transduction. Farnesylation facilitates their membrane association and also promotes protein-protein interaction. Recently, progress has been made in understanding the biological significance of farnesylation. First, effects of farnesyltransferase inhibitors (FTIs) on cancer cells have been examined using a variety of human cancer cells. This study showed that one of the major effects of FTIs is to alter cell cycle progression. Both G0/G1 enrichment and G2/M accumulation were observed depending on the cell line examined. Second, a number of novel farnesylated proteins have been characterized. Of these, Rheb and CENP-E,F are of particular interest. Rheb, a novel member of the Ras superfamily G-proteins, may play a role in the G1 phase of the cell cycle. CENP-E,F are centromere associated motors that play critical roles in mitosis. These results suggest important contributions of farnesylated proteins in the regulation of cell cycle progression. (C) 2002 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available